Request a copy

Full Text

• Apple F.S. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106 (2002) 2941-2945
• Apple F.S., Murakami M.M., Lesly A.P., and Herzog C.A. Multiple-Biomarker Stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive Protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50 12 (2004) 2279-2285
• Benamer H., Lefèvre J.-J., Debure A., and Gaultier C. Coronaropathie et angioplastie coronaire dans l'insuffisance rénale dialysée. Ann Cardiol Angeiol 53 (2007) 10-15
• Bettencourt P., Azevedo A., Pimenta J., Friões F., Ferreira S., and Ferreira A. N-terminal pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
• Chapelle J.-P., Dubois B., Bovy C., Aldenhoff M.-C., Gielen J., and Rorive G. Comparison of plasma cardiac troponins T and I in chronically hemodialyzed patients in relation to cardiac status and age. Clin Chem lab Med 40 3 (2002) 240-245
• deFilippi C., Wasserman S., Rosanio S., Tiblier E., Sperger H., Tocchi M., et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. J Am Med Assoc 290 (2003) 353-359
• Gardner R.S., Ozalp F., Murday A.J., Robb S.D., and McDonagh T.A. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur heart J 24 (2003) 1735-1743
• Goetze J.-P., Jensen G., Moller S., Bendtsen F., Rehfeld J.-F., and Henriksen J.H. BNP and N-treminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 36 (2006) 8-15
• Gordon W.M., Howlett J., Januzzi J.L., and Zowall H. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation 115 (2007) 3103-3110
• Hall C. Essential biochemistry and physiology of NT-proBNP. Eur J Heart Fail 6 (2004) 257-260
• Heeschen C., Hamm C.W., Mitrovic V., Lantelme N.H., and White H.D. Platelet receptor inhibition in ischemic syndrome management (PRISM) investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
• Ilioun M.C., Fumeron C., Benoit M.O., Tuppin P., Courvoisier C.L., Calonge V.M., et al. factors associated with increased serum levels of cardiac troponin T and I in chronic hemodialysis patients: chronic hemodialysis new cardiac markers evaluation (CHANCE) study. Nephrol Dial Transplant 16 (2001) 1452-1458
• Khan N.A., Hemmelgarn B.R., Tonelli M., Thompson C.R., and Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 112 (2005) 3088-3096
• Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., and Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293 (2005) 1609-1616
• Lamb E.J., Webb M.C., and Abbas N.A. The significance of serum troponin T in patients with kidney disease: a review of the literature. Ann Clin Biochem 41 (2004) 1-9
• Madsen L.H., Ladefoged S., Corell P., Schou M., Hildebarandt P.R., and Atar D. N-terminal pro-brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 71 (2007) 548-554
• Mallamaci F., Zoccali C., Parlongo S., Tripepi G., Benedetto F.A., Cutrupi S., et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J kidney Dis 40 (2002) 68-75
• McCullough P.A., Omland FT., and Maisel A.S. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev cardiovasc Med 4 (2003) 72-80
• McCullough P.A., and Sandberg K.R. B-type natriuretic peptide and renal disease. Heart Fail Rev 8 (2003) 355-358
• Olsen M.H., Watchell K., Tuxen C., et al., A LIFE study. N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy. J Hypertens 22 (2004) 1597-1604
• Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., et al. N-terminal pro-brain natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106 (2002) 2913-2918
• Sommerer C., Beimler J., Schwenger V., Heckele N., Katus H.A., Giannitsis M., and Zeier M. Cardiac biomarkers and survival in hemodialysis patients. Eur J Clin Invest 37 (2007) 350-356
• Spanaus K.-S., Kronenberg F., Ritz E., Schlapbach R., Fliser D., Hersberger M., et al. B-Type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the mild-to-moderate kidney disease study. Clin Chem 53 7 (2007) 1264-1272
• Stolear J.C., Georges B., Shita A., and Verbeelen D. The predictive value of cardiac troponin T measurements in subjects on regular hemodialysis. Nephrol Dial transplant 14 (1999) 1961-1967
• van Kimmenade R.R.J., Januzzi J.L., Baggish A.L., Lainchbury J.G., Bayes-Genis A., Richards A.M., et al. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure. J Am Coll Cardiol 48 (2006) 1621-1627
• Wright S.P., Doughty R.N., Pearl A., Gamble G.D., Whalley G.A., Walsh H.J., et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 42 (2003) 1793-1800